|
[1]
|
Toussaint, A., Weiss, E., Khoy-Ear, L., et al. (2016) Prognostic Value of Preoperative Brain Natriuretic Peptide Serum Levels in Liver Transplantation. Transplantation, 100, 819-824. [Google Scholar] [CrossRef]
|
|
[2]
|
Sharma, S., Sonny, A., Dalia, A.A., et al. (2020) Acute Heart Failure after Liver Transplantation: A Narrative Review. Clinical Transplantation, 34, e14079. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Konerman, M.A., Fritze, D., Weinberg, R.L., et al. (2017) Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes after Liver Transplantation. Transplantation, 101, 1645-1657. [Google Scholar] [CrossRef]
|
|
[4]
|
Koshy, A.N., Gow, P.J., Han, H.C., et al. (2021) Sudden Cardiac Death Following Liver Transplantation: Incidence, Trends and Risk Predictors. International Journal of Cardiology, 327, 171-174. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Piek, A., Du, W., De Boer, R.A., et al. (2018) Novel Heart Failure Biomarkers: Why Do We Fail to Exploit Their Potential? Critical Reviews in Clinical Laboratory Sciences, 55, 246-263. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
York, M.K., Gupta, D.K., Reynolds, C.F., et al. (2018) B-Type Natriuretic Peptide Levels and Mortality in Patients with and without Heart Failure. Journal of the American College of Cardiology, 71, 2079-2088. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chahal, D., Yau, A., Casciato, P., et al. (2019) B-Type Peptides to Predict Post-Liver Transplant Mortality: Systematic Review and Meta-Analysis. Canadian Liver Journal, 2, 4-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Chung, H.S., Woo, A., Chae, M.S., et al. (2021) Combined B-Type Natriuretic Peptide as Strong Predictor of Short-Term Mortality in Patients after Liver Transplantation. International Journal of Medical Sciences, 18, 2500-2509. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Scarlatescu, E., Marchenko, S.P. and Tomescu, D.R. (2020) Cirrhotic Cardiomyopathy—A Veiled Threat. Cardiology in Review, 30, 80-89. [Google Scholar] [CrossRef]
|
|
[10]
|
Kaur, H. and Premkumar, M. (2022) Diagnosis and Management of Cirrhotic Cardiomyopathy. Journal of Clinical and Experimental Hepatology, 12, 186-199. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Fede, G., Privitera, G., Tomaselli, T., et al. (2015) Cardiovascular Dysfunction in Patients with Liver Cirrhosis. Annals of Gastroenterology, 28, 31-40.
|
|
[12]
|
Møller, S. and Bendtsen, F. (2015) Cirrhotic Multiorgan Syndrome. Digestive Diseases and Sciences, 60, 3209-3225. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Møller, S., Danielsen, K.V., Wiese, S., et al. (2019) An Update on Cirrhotic Cardiomyopathy. Expert Review of Gastroenterology & Hepatology, 13, 497-505. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Feng, A.C., Fan, H.L., Chen, T.W., et al. (2014) Hepatic Hemodynamic Changes during Liver Transplantation: A Review. World Journal of Gastroenterology, 20, 11131-11141. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
李文磊, 栗光明. 肝移植受者术前心脏疾病风险评估的现状及展望[J]. 器官移植, 2023, 14(4): 605-611.
|
|
[16]
|
Aggarwal, S., Kang, Y., Freeman, J.A., et al. (1987) Postreperfusion Syndrome: Cardiovascular Collapse Following Hepatic Reperfusion during Liver Transplantation. Transplantation Proceedings, 19, 54-55.
|
|
[17]
|
Feltracco, P., Barbieri, S., Carollo, C., et al. (2019) Early Circulatory Complications in Liver Transplant Patients. Transplantation Reviews, 33, 219-230. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ma, Z. and Lee, S.S. (1996) Cirrhotic Cardiomyopathy: Getting to the Heart of the Matter. Hepatology, 24, 451-459. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Beltrami, M., Palazzuoli, A., Ruocco, G., et al. (2016) The Predictive Value of Plasma Biomarkers in Discharged Heart Failure Patients: The Role of Plasma BNP. Minerva Cardioangiologica, 64, 147-156.
|
|
[20]
|
Moroni, F., Gertz, Z. and Azzalini, L. (2021) Relief of Ischemia in Ischemic Cardiomyopathy. Current Cardiology Reports, 23, Article No. 80. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Souki, F.G., Raveh, Y., Sancassani, R., et al. (2023) Characteristics, Risk Factors, and Outcome of New-Onset Systolic Heart Failure after Liver Transplantation: A Single-Center Cohort. Transplant Direct, 9, e1499. [Google Scholar] [CrossRef]
|
|
[22]
|
Diedrich, D.A., Findlay, J.Y., Harrison, B.A., et al. (2008) Influence of Coronary Artery Disease on Outcomes after Liver Transplantation. Transplantation Proceedings, 40, 3554-3557. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Plotkin, J.S., Scott, V.L., Pinna, A., et al. (1996) Morbidity and Mortality in Patients with Coronary Artery Disease Undergoing Orthotopic Liver Transplantation. Liver Transplant Surgery, 2, 426-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Palazzuoli, A., Gennari, L., Calabria, P., et al. (2005) Relation of Plasma Brain Natriuretic Peptide Levels in Non-ST-Elevation Coronary Disease and Preserved Systolic Function to Number of Narrowed Coronary Arteries. The American Journal of Cardiology, 96, 1705-1710. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Snipelisky, D.F., Mcree, C., Seeger, K., et al. (2015) Coronary Interventions before Liver Transplantation Might Not Avert Postoperative Cardiovascular Events. Texas Heart Institute Journal, 42, 438-442. [Google Scholar] [CrossRef]
|
|
[26]
|
Maisch, B. (2016) Alcoholic Cardiomyopathy: The Result of Dosage and Individual Predisposition. Herz, 41, 484-493. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Movva, R. and Figueredo, V.M. (2013) Alcohol and the Heart: To Abstain or Not to Abstain? International Journal of Cardiology, 164, 267-276. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Guzzo-Merello, G., Cobo-Marcos, M., Gallego-Delgado, M., et al. (2014) Alcoholic Cardiomyopathy. World Journal of Cardiology, 6, 771-781. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Wang, C., Gao, H., Liu, W., et al. (2023) Alcoholic Cardiomyopathy in Patients with Alcoholic Liver Cirrhosis: A Study Across 10 Years. European Journal of Gastroenterology & Hepatology, 35, 600-603. [Google Scholar] [CrossRef]
|
|
[30]
|
Matyas, C., Varga, Z.V., Mukhopadhyay, P., et al. (2016) Chronic Plus Binge Ethanol Feeding Induces Myocardial Oxidative Stress, Mitochondrial and Cardiovascular Dysfunction, and Steatosis. American Journal of Physiology-Heart and Circulatory Physiology, 310, H1658-H1670. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Ballestri, S., Lonardo, A., Bonapace, S., et al. (2014) Risk of Cardiovascular, Cardiac and Arrhythmic Complications in Patients with Non-Alcoholic Fatty Liver Disease. World Journal of Gastroenterology, 20, 1724-1745. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Bonapace, S., Perseghin, G., Molon, G., et al. (2012) Nonalcoholic Fatty Liver Disease Is Associated with Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes. Diabetes Care, 35, 389-395. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Cosarderelioglu, C., Cosar, A.M., Gurakar, M., et al. (2016) Portopulmonary Hypertension and Liver Transplant: Recent Review of the Literature. Experimental and Clinical Transplantation, 14, 113-120.
|
|
[34]
|
Talwalkar, J.A., Swanson, K.L., Krowka, M.J., et al. (2011) Prevalence of Spontaneous Portosystemic Shunts in Patients with Portopulmonary Hypertension and Effect on Treatment. Gastroenterology, 141, 1673-1679. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Krowka, M.J., Plevak, D.J., Findlay, J.Y., et al. (2000) Pulmonary Hemodynamics and Perioperative Cardiopulmonary-Related Mortality in Patients with Portopulmonary Hypertension Undergoing Liver Transplantation. Liver Transplantation, 6, 443-450. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Swanson, K.L., Wiesner, R.H. and Krowka, M.J. (2005) Natural History of Hepatopulmonary Syndrome: Impact of Liver Transplantation. Hepatology, 41, 1122-1129. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Saab, S., Landaverde, C., Ibrahim, A.B., et al. (2006) The MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality. Experimental and Clinical Transplantation, 4, 395-399.
|
|
[38]
|
Abe, S., Yoshihisa, A., Takiguchi, M., et al. (2014) Liver Dysfunction Assessed by Model for End-Stage Liver Disease Excluding INR (MELD-XI) Scoring System Predicts Adverse Prognosis in Heart Failure. PLOS ONE, 9, e100618. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Kwon, H.M., Moon, Y.J., Kim, K.S., et al. (2021) Prognostic Value of B-Type Natriuretic Peptide in Liver Transplant Patients: Implication in Posttransplant Mortality. Hepatology, 74, 336-350. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Hendrickson, J.E., Roubinian, N.H., Chowdhury, D., et al. (2016) Incidence of Transfusion Reactions: A Multicenter Study Utilizing Systematic Active Surveillance and Expert Adjudication. Transfusion, 56, 2587-2596. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Hernandez-Guerra, M., Lopez, E., Bellot, P., et al. (2006) Systemic Hemodynamics, Vasoactive Systems, and Plasma Volume in Patients with Severe Budd-Chiari Syndrome. Hepatology, 43, 27-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Mueller, C., Mcdonald, K., De Boer, R.A., et al. (2019) Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations. European Journal of Heart Failure, 21, 715-731. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis. Journal of Hepatology, 69, 406-460. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Izzy, M., Fortune, B.E., Serper, M., et al. (2022) Management of Cardiac Diseases in Liver Transplant Recipients: Comprehensive Review and Multidisciplinary Practice-Based Recommendations. American Journal of Transplantation, 22, 2740-2758. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Lim, W.H., Chew, N.W., Quek, J., et al. (2022) Echocardiographic Assessment of Cardiovascular Function and Clinical Outcomes in Liver Transplant Recipients. Clinical Transplantation, 36, e14793. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Kaski, J.C., Crea, F., Gersh, B.J., et al. (2018) Reappraisal of Ischemic Heart Disease. Circulation, 138, 1463-1480. [Google Scholar] [CrossRef]
|
|
[47]
|
Patel, S.S., Nabi, E., Guzman, L., et al. (2018) Coronary Artery Disease in Decompensated Patients Undergoing Liver Transplantation Evaluation. Liver Transplantation, 24, 333-342. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
吉晓琳, 张欢, 黄佳鹏. 经食道心脏超声在肝移植手术中的应用[J]. 麻醉安全与质控, 2020, 4(1): 53-57.
|
|
[49]
|
Mazilescu, L.I., Bezinover, D., Paul, A., et al. (2018) Unrecognized Esophageal Perforation after Liver Transplantation. Journal of Cardiothoracic and Vascular Anesthesia, 32, 1407-1410. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Moguilevitch, M., Rufino, M., Leff, J., et al. (2015) Novel Approach for Heart Failure Treatment after Liver Transplantation. Liver Transplantation, 21, 1103-1104. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Palanisamy, A.P., Nadig, S.N., Chedister, G.R., et al. (2017) Use of Intra-Aortic Counterpulsation in Cardiogenic Shock Post-Liver Transplantation. Clinical Transplantation, 31, e13002. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Justo, I., Marcacuzco, A., Caso, Ó., et al. (2023) Risk Factors of Massive Blood Transfusion in Liver Transplantation: Consequences and a New Index for Prediction Including the Donor. Cirugía Española (English Edition), 101, 684-692. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Galiè, N., Mclaughlin, V.V., Rubin, L.J., et al. (2019) An Overview of the 6th World Symposium on Pulmonary Hypertension. European Respiratory Journal, 53, Article 1802148. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Preston, I.R., Burger, C.D., Bartolome, S., et al. (2020) Ambrisentan in Portopulmonary Hypertension: A Multicenter, Open-Label Trial. The Journal of Heart and Lung Transplantation, 39, 464-472. [Google Scholar] [CrossRef] [PubMed]
|